Riverside Partners' Portfolio Company, Syner-G BioPharma Group, Appoints Ron Kraus as CEO

/PRNewswire/ -- Riverside Partners, a Boston based private equity firm, announced today that its portfolio company, Syner-G BioPharma Group ("Syner-G" or the...

Related Keywords

Boston ,Massachusetts ,United States ,Ron Kraus ,Randy Merrill ,David Belluck ,Prabu Nambiar ,Parexel International ,Impact Pharmaceutical Services ,Biopharma Group ,Riverside Partners ,Synerg Biopharma Group ,Chief Executive Officer ,Chief Operating Officer ,Global Head ,Parexel Consulting ,Craig Stern ,General Partner ,